Uploaded by CRIMSON MUPAS

3rd year 2nd sem midterms HEMA LEC 2 midterms transes

advertisement
#separator:tab
#html:true
"Factor <span class=""cloze"" data-cloze=""VII"" data-ordinal=""1"">[...]</span> and <span class=""cloze"" data-cloze=""XI"" data-ordinal=""1"">[...]</span> tend to be prematurely activated at ref<br>temp (4 deg C)""Factor <span class=""cloze"" data-ordinal=""1"">VII</span> and <span class=""cloze"" data-ordinal=""1"">XI</span> tend to be prematurely activated at ref<br>temp (4 deg C)<br>
"
"If samples are left at room temperature for an extended time,<br>factors <span class=""cloze"" data-cloze=""V"" data-ordinal=""1"">[...]</span> and <span class=""cloze"" data-cloze=""VIII"" data-ordinal=""1"">[...]</span> are likely to deteriorate.""If samples are left at room temperature for an extended time,<br>factors <span class=""cloze"" data-ordinal=""1"">V</span> and <span class=""cloze"" data-ordinal=""1"">VIII</span> are likely to deteriorate.<br>
"
"Normal samples collected in evacuated tubes and stored at<br>room temperature for as long as <span class=""cloze"" data-cloze=""6"" data-ordinal=""1"">[...]</span> hours show no significant<br>changes in PT or APTT results""Normal samples collected in evacuated tubes and stored at<br>room temperature for as long as <span class=""cloze"" data-ordinal=""1"">6</span> hours show no significant<br>changes in PT or APTT results<br>
"
"EDTA effects:<br>- inhibits <span class=""cloze"" data-cloze=""fibrinogen-thrombin"" data-ordinal=""1"">[...]</span> reaction.<br>- destabilizes factor <span class=""cloze"" data-cloze=""V"" data-ordinal=""1"">[...]</span>""EDTA effects:<br>- inhibits <span class=""cloze"" data-ordinal=""1"">fibrinogen-thrombin</span> reaction.<br>- destabilizes factor <span class=""cloze"" data-ordinal=""1"">V</span><br>
"
"<span style=""color: rgb(85, 255, 255);"">Prolonged tourniquet<br>application</span><br><ul><li>Stasis elevates the concentration of <span class=""cloze"" data-cloze=""vWF"" data-ordinal=""1"">[...]</span> and factor <span class=""cloze"" data-cloze=""VIII"" data-ordinal=""1"">[...]</span></li><li>Falsely decreases <span class=""cloze"" data-cloze=""fibrinolytic parameters"" data-ordinal=""1"">[...]</span>; and</li><li>Falsely shortens <span class=""cloze"" data-cloze=""clot-based"" data-ordinal=""1"">[...]</span> test results.</li></ul>""<span style=""color: rgb(85, 255, 255);"">Prolonged tourniquet<br>application</span><br><ul><li>Stasis elevates the concentration of <span class=""cloze"" data-ordinal=""1"">vWF</span> and factor <span class=""cloze"" data-ordinal=""1"">VIII</span></li><li>Falsely decreases <span class=""cloze"" data-ordinal=""1"">fibrinolytic parameters</span>; and</li><li>Falsely shortens <span class=""cloze"" data-ordinal=""1"">clot-based</span> test results.</li></ul><br>
"
"Storage at <span style=""color: rgb(85, 255, 255);"">refrigerator</span> temperatures<br><ul><li>precipitation of large <span class=""cloze"" data-cloze=""vwf"" data-ordinal=""1"">[...]</span> multimers</li><li>activation of factor <span class=""cloze"" data-cloze=""VII"" data-ordinal=""1"">[...]</span></li><li>destroys platelet integrity</li></ul>""Storage at <span style=""color: rgb(85, 255, 255);"">refrigerator</span> temperatures<br><ul><li>precipitation of large <span class=""cloze"" data-ordinal=""1"">vwf</span> multimers</li><li>activation of factor <span class=""cloze"" data-ordinal=""1"">VII</span></li><li>destroys platelet integrity</li></ul><br>
"
"9:1 blood-to-anticoagulant ratio is effective, provided the<br>patient’s hematocrit is <span class=""cloze"" data-cloze=""55"" data-ordinal=""1"">[...]</span>% or less""9:1 blood-to-anticoagulant ratio is effective, provided the<br>patient’s hematocrit is <span class=""cloze"" data-ordinal=""1"">55</span>% or less<br>
"
"formula for computing needed volume of anticoagulant for a given volume of specimen<br><span class=""cloze"" data-cloze=""<img src="paste-608737046cb3bc66351e423b820a4613e11d8649.jpg">"" data-ordinal=""1"">[...]</span>""formula for computing needed volume of anticoagulant for a given volume of specimen<br><span class=""cloze"" data-ordinal=""1""><img src=""paste-608737046cb3bc66351e423b820a4613e11d8649.jpg""></span><br>
"
"<span class=""cloze"" data-cloze=""Heparin"" data-ordinal=""1"">[...]</span> acts with anti- thrombin III and<br>inhibits the reactions of all stages of coagulation""<span class=""cloze"" data-ordinal=""1"">Heparin</span> acts with anti- thrombin III and<br>inhibits the reactions of all stages of coagulation<br>
"
"For most coagulation testing, PPP is required.<br>○ This PPP is prepared by centrifuging<br>anticoagulated blood at <span class=""cloze"" data-cloze=""2000"" data-ordinal=""1"">[...]</span>x g for <span class=""cloze"" data-cloze=""10"" data-ordinal=""1"">[...]</span> mins""For most coagulation testing, PPP is required.<br>○ This PPP is prepared by centrifuging<br>anticoagulated blood at <span class=""cloze"" data-ordinal=""1"">2000</span>x g for <span class=""cloze"" data-ordinal=""1"">10</span> mins<br>
"
"The <span style=""color: rgb(85, 255, 255);"">use of PPP</span> is essential for technical reasons:<br>● Platelets contain <span class=""cloze"" data-cloze=""platelet factor 4 (PF4)"" data-ordinal=""1"">[...]</span>, which neutralizes<br><span style=""color: rgb(85, 255, 255);"">heparin</span> (thus affecting sample’s testing for the presence of<br>heparin)<br>● Platelets contain <span class=""cloze"" data-cloze=""phospholipids"" data-ordinal=""1"">[...]</span>, which affect<span style=""color: rgb(85, 255, 255);""> lupus<br>anticoagulant testing and factor assay testing</span> (especially if<br>the sample is frozen and thawed).<br>● Platelets also contain <span class=""cloze"" data-cloze=""proteases"" data-ordinal=""1"">[...]</span>, which, when released<br>during the thawing of a frozen sample, can alter results for<br><span style=""color: rgb(85, 255, 255);"">von Willebrand factor testing.</span>""The <span style=""color: rgb(85, 255, 255);"">use of PPP</span> is essential for technical reasons:<br>● Platelets contain <span class=""cloze"" data-ordinal=""1"">platelet factor 4 (PF4)</span>, which neutralizes<br><span style=""color: rgb(85, 255, 255);"">heparin</span> (thus affecting sample’s testing for the presence of<br>heparin)<br>● Platelets contain <span class=""cloze"" data-ordinal=""1"">phospholipids</span>, which affect<span style=""color: rgb(85, 255, 255);""> lupus<br>anticoagulant testing and factor assay testing</span> (especially if<br>the sample is frozen and thawed).<br>● Platelets also contain <span class=""cloze"" data-ordinal=""1"">proteases</span>, which, when released<br>during the thawing of a frozen sample, can alter results for<br><span style=""color: rgb(85, 255, 255);"">von Willebrand factor testing.</span><br>
"
"The PTT measures all factors except <span class=""cloze"" data-cloze=""VII"" data-ordinal=""1"">[...]</span> and <span class=""cloze"" data-cloze=""XIII"" data-ordinal=""1"">[...]</span>.""The PTT measures all factors except <span class=""cloze"" data-ordinal=""1"">VII</span> and <span class=""cloze"" data-ordinal=""1"">XIII</span>.<br>
"
"In PTT, <span class=""cloze"" data-cloze=""Phospholipid"" data-ordinal=""1"">[...]</span> is supplied to substitute for platelet factor 3<br>(PF3).""In PTT, <span class=""cloze"" data-ordinal=""1"">Phospholipid</span> is supplied to substitute for platelet factor 3<br>(PF3).<br>
"
"Stasis elevates the concentration of <span class=""cloze"" data-cloze=""vWF"" data-ordinal=""1"">[...]</span> and factor
<span class=""cloze"" data-cloze=""VIII"" data-ordinal=""1"">[...]</span>;""Stasis elevates the concentration of <span class=""cloze"" data-ordinal=""1"">vWF</span> and factor
<span class=""cloze"" data-ordinal=""1"">VIII</span>;<br>
"
"Px has polycythemia, are clot based coagulation tests prolonged or shortened?<br><br><span class=""cloze"" data-cloze=""prolonged"" data-ordinal=""1"">[...]</span>""Px has polycythemia, are clot based coagulation tests prolonged or shortened?<br><br><span class=""cloze"" data-ordinal=""1"">prolonged</span><br>
"
"true or false<br><br>Sequestrene, but not EDTA, is NOT a satisfactory anticoagulant for
coagulation testing because it inhibits the
fibrinogen-thrombin reaction.<br><br><span class=""cloze"" data-cloze=""false. Both sequestrene and EDTA are not suitable for coagulation testing"" data-ordinal=""1"">[...]</span>""true or false<br><br>Sequestrene, but not EDTA, is NOT a satisfactory anticoagulant for
coagulation testing because it inhibits the
fibrinogen-thrombin reaction.<br><br><span class=""cloze"" data-ordinal=""1"">false. Both sequestrene and EDTA are not suitable for coagulation testing</span><br>
"
"what factor is not stable in the presence of EDTA<br><span class=""cloze"" data-cloze=""factor V"" data-ordinal=""1"">[...]</span>""what factor is not stable in the presence of EDTA<br><span class=""cloze"" data-ordinal=""1"">factor V</span><br>
"
"what anticoagulant inhibits the reactions of all stages of coagulation <br><span class=""cloze"" data-cloze=""heparin"" data-ordinal=""1"">[...]</span>""what anticoagulant inhibits the reactions of all stages of coagulation <br><span class=""cloze"" data-ordinal=""1"">heparin</span><br>
"
"anticoagulant of choice when blood is
collected for the platelet retention test<br><br><span class=""cloze"" data-cloze=""heparin"" data-ordinal=""1"">[...]</span>""anticoagulant of choice when blood is
collected for the platelet retention test<br><br><span class=""cloze"" data-ordinal=""1"">heparin</span><br>
"
"Factors <span class=""cloze"" data-cloze=""VII"" data-ordinal=""1"">[...]</span> and <span class=""cloze"" data-cloze=""XI"" data-ordinal=""1"">[...]</span> tend to be prematurely activated at ref
temp (4 deg C)""Factors <span class=""cloze"" data-ordinal=""1"">VII</span> and <span class=""cloze"" data-ordinal=""1"">XI</span> tend to be prematurely activated at ref
temp (4 deg C)<br>
"
"If samples are left at room temperature for an extended time,
factors <span class=""cloze"" data-cloze=""V"" data-ordinal=""1"">[...]</span> and <span class=""cloze"" data-cloze=""VIII"" data-ordinal=""1"">[...]</span> are likely to deteriorate.""If samples are left at room temperature for an extended time,
factors <span class=""cloze"" data-ordinal=""1"">V</span> and <span class=""cloze"" data-ordinal=""1"">VIII</span> are likely to deteriorate.<br>
"
"PPP is prepared by centrifuging
anticoagulated blood at <span class=""cloze"" data-cloze=""2000"" data-ordinal=""1"">[...]</span> x g for <span class=""cloze"" data-cloze=""10"" data-ordinal=""1"">[...]</span> mins""PPP is prepared by centrifuging
anticoagulated blood at <span class=""cloze"" data-ordinal=""1"">2000</span> x g for <span class=""cloze"" data-ordinal=""1"">10</span> mins<br>
"
"true or false<br><br>Samples can be frozen if testing can be done within 4 hours after collection<br><span class=""cloze"" data-cloze=""<br>True. The general rule of thumb is that samples shouldn't be frozen if you can test them in two hours"" data-ordinal=""1"">[...]</span>""true or false<br><br>Samples can be frozen if testing can be done within 4 hours after collection<br><span class=""cloze"" data-ordinal=""1""><br>True. The general rule of thumb is that samples shouldn't be frozen if you can test them in two hours</span><br>
"
"If frozen properly → fibrinogen is stable for at least <span class=""cloze"" data-cloze=""4"" data-ordinal=""1"">[...]</span> hours
after thawing and survives freezing and thawing""If frozen properly → fibrinogen is stable for at least <span class=""cloze"" data-ordinal=""1"">4</span> hours
after thawing and survives freezing and thawing<br>
"
"Frozen samples must be thawed rapidly at 37°C because excessive
heating (75 minutes) can result in the loss of the factors <span class=""cloze"" data-cloze=""V"" data-ordinal=""1"">[...]</span> and
<span class=""cloze"" data-cloze=""VIII"" data-ordinal=""1"">[...]</span>.""Frozen samples must be thawed rapidly at 37°C because excessive
heating (75 minutes) can result in the loss of the factors <span class=""cloze"" data-ordinal=""1"">V</span> and
<span class=""cloze"" data-ordinal=""1"">VIII</span>.<br>
(because they are labile)"
"true or false<br><br>Only PPP is used for plasma recalcification time due to its advantages over PRP<br><br><span class=""cloze"" data-cloze=""false, PPP or PRP, or both can be used"" data-ordinal=""1"">[...]</span>""true or false<br><br>Only PPP is used for plasma recalcification time due to its advantages over PRP<br><br><span class=""cloze"" data-ordinal=""1"">false, PPP or PRP, or both can be used</span><br>
"
"<span style=""color: rgb(85, 255, 255);"">Plasma Recalcification Time</span> is based on the fact that except for <span class=""cloze"" data-cloze=""calcium"" data-ordinal=""1"">[...]</span>, normal
<span style=""color: rgb(85, 255, 255);"">PRP</span> contains all the components of the coagulation
mechanism. ""<span style=""color: rgb(85, 255, 255);"">Plasma Recalcification Time</span> is based on the fact that except for <span class=""cloze"" data-ordinal=""1"">calcium</span>, normal
<span style=""color: rgb(85, 255, 255);"">PRP</span> contains all the components of the coagulation
mechanism. <br>
"
"Plasma recalcification time is a general measure for the <span class=""cloze"" data-cloze=""intrinsic"" data-ordinal=""1"">[...]</span> and common pathways""Plasma recalcification time is a general measure for the <span class=""cloze"" data-ordinal=""1"">intrinsic</span> and common pathways<br>
"
"In plasma recalcification time, using a parallel test on PPP can screen <span class=""cloze"" data-cloze=""platelet function"" data-ordinal=""1"">[...]</span> defects.""In plasma recalcification time, using a parallel test on PPP can screen <span class=""cloze"" data-ordinal=""1"">platelet function</span> defects.<br>
"
"What test used diatomite as coagulants<br><span class=""cloze"" data-cloze=""Activated clotting time"" data-ordinal=""1"">[...]</span>""What test used diatomite as coagulants<br><span class=""cloze"" data-ordinal=""1"">Activated clotting time</span><br>
"
"The two tubes in ACT should agree within <span class=""cloze"" data-cloze=""10"" data-ordinal=""1"">[...]</span> seconds""The two tubes in ACT should agree within <span class=""cloze"" data-ordinal=""1"">10</span> seconds<br>
"
"What test is best used for procedures requiring
extracorporeal circulation, in which frequent testing and
rapid turnaround time are required<br><span class=""cloze"" data-cloze=""<br>Activated clotting time (ACT)"" data-ordinal=""1"">[...]</span>""What test is best used for procedures requiring
extracorporeal circulation, in which frequent testing and
rapid turnaround time are required<br><span class=""cloze"" data-ordinal=""1""><br>Activated clotting time (ACT)</span><br>
"
"This test has enjoyed considerable popularity of late
as a ""point-of-care"" test.<br><span class=""cloze"" data-cloze=""<br>ACT&nbsp&#x3B;"" data-ordinal=""1"">[...]</span>""This test has enjoyed considerable popularity of late
as a ""point-of-care"" test.<br><span class=""cloze"" data-ordinal=""1""><br>ACT </span><br>
"
"What test does not have a suitable quality control procedure<br><span class=""cloze"" data-cloze=""ACT"" data-ordinal=""1"">[...]</span>""What test does not have a suitable quality control procedure<br><span class=""cloze"" data-ordinal=""1"">ACT</span><br>
<br>Other than the <span style=""color: rgb(85, 255, 255);"">duplicate testing</span>, there is no suitable
method of quality control"
"test of choice to screen for factor deficiencies of the intrinsic and common pathways<br><br><span class=""cloze"" data-cloze=""Partial Thromboplastime Time"" data-ordinal=""1"">[...]</span>""test of choice to screen for factor deficiencies of the intrinsic and common pathways<br><br><span class=""cloze"" data-ordinal=""1"">Partial Thromboplastime Time</span><br>
"
"test of
choice to monitor heparin therapy <br><span class=""cloze"" data-cloze=""Partial Thromboplastin Time"" data-ordinal=""1"">[...]</span>""test of
choice to monitor heparin therapy <br><span class=""cloze"" data-ordinal=""1"">Partial Thromboplastin Time</span><br>
"
"Molar concentration of CaC2 required in PT<br><span class=""cloze"" data-cloze=""0.025"" data-ordinal=""1"">[...]</span> M""Molar concentration of CaC2 required in PT<br><span class=""cloze"" data-ordinal=""1"">0.025</span> M<br>
"
"The citrated PPP and APTT reagent are incubated at 37°C
for approximately <span class=""cloze"" data-cloze=""3"" data-ordinal=""1"">[...]</span> minutes""The citrated PPP and APTT reagent are incubated at 37°C
for approximately <span class=""cloze"" data-ordinal=""1"">3</span> minutes<br>
"
"coag factors evaluated by APTT<br>= <span class=""cloze"" data-cloze=""XII, HMWK, PK"" data-ordinal=""1"">[...]</span>""coag factors evaluated by APTT<br>= <span class=""cloze"" data-ordinal=""1"">XII, HMWK, PK</span><br>
"
"reference range of APTT<br><span class=""cloze"" data-cloze=""25 - 35 seconds"" data-ordinal=""1"">[...]</span>""reference range of APTT<br><span class=""cloze"" data-ordinal=""1"">25 - 35 seconds</span><br>
"
"screening test for extrinsic pathway proteins<br><span class=""cloze"" data-cloze=""Prothrombin Time"" data-ordinal=""1"">[...]</span>""screening test for extrinsic pathway proteins<br><span class=""cloze"" data-ordinal=""1"">Prothrombin Time</span><br>
"
"PT used in the modern laboratory
screens for deficiencies of factors <span class=""cloze"" data-cloze=""I, II, V, VII, and
X."" data-ordinal=""1"">[...]</span>""PT used in the modern laboratory
screens for deficiencies of factors <span class=""cloze"" data-ordinal=""1"">I, II, V, VII, and
X.</span><br>
"
"Test of choice for monitoring anticoagulant therapy by
vitamin K antagonists<br><span class=""cloze"" data-cloze=""Prothrombin time"" data-ordinal=""1"">[...]</span>""Test of choice for monitoring anticoagulant therapy by
vitamin K antagonists<br><span class=""cloze"" data-ordinal=""1"">Prothrombin time</span><br>
"
"Three of the five factors measured by the PT are
sensitive to and depressed by anticoagulants that are vitamin K antagonists. What are they<br><span class=""cloze"" data-cloze=""II, VII, X"" data-ordinal=""1"">[...]</span>""Three of the five factors measured by the PT are
sensitive to and depressed by anticoagulants that are vitamin K antagonists. What are they<br><span class=""cloze"" data-ordinal=""1"">II, VII, X</span><br>
"
"Only factor <span class=""cloze"" data-cloze=""IX"" data-ordinal=""1"">[...]</span>, the other factor depressed by vitamin K
antagonists, is not detected by the PT ""Only factor <span class=""cloze"" data-ordinal=""1"">IX</span>, the other factor depressed by vitamin K
antagonists, is not detected by the PT <br>
"
"Prothrombin time uses what type of plasma<br><span class=""cloze"" data-cloze=""PPP"" data-ordinal=""1"">[...]</span>""Prothrombin time uses what type of plasma<br><span class=""cloze"" data-ordinal=""1"">PPP</span><br>
"
"two most common sources of thromboplastin for prothrombin time are<br>= <span class=""cloze"" data-cloze=""rabbit brain"" data-ordinal=""1"">[...]</span><br>= recombinant human tissue factor""two most common sources of thromboplastin for prothrombin time are<br>= <span class=""cloze"" data-ordinal=""1"">rabbit brain</span><br>= recombinant human tissue factor<br>
"
Download